Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer

Evan M. Graboyes, Katherine R. Sterba, Hong Li, Graham W. Warren, Anthony J. Alberg, Elizabeth A. Calhoun, Brian Nussenbaum, Jessica McCay, Courtney H. Marsh, Nosayaba Osazuwa-Peters, David M. Neskey, John M. Kaczmar, Anand K. Sharma, Jennifer Harper, Terry A. Day, Chanita Hughes-Halbert

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Abstract

PURPOSE More than half of patients with head and neck squamous cell carcinoma (HNSCC) experience a delay initiating guideline-adherent postoperative radiation therapy (PORT), contributing to excess mortality and racial disparities in survival. However, interventions to improve the delivery of timely, equitable PORT among patients with HNSCC are lacking. This study (1) describes the development of NDURE (Navigation for Disparities and Untimely Radiation thErapy), a navigation-based multilevel intervention (MLI) to improve guideline-adherent PORT and (2) evaluates its feasibility, acceptability, and preliminary efficacy. METHODS NDURE was developed using the six steps of intervention mapping (IM). Subsequently, NDURE was evaluated by enrolling consecutive patients with locally advanced HNSCC undergoing surgery and PORT (n 5 15) into a single-arm clinical trial with a mixed-methods approach to process evaluation. RESULTS NDURE is a navigation-based MLI targeting barriers to timely, guideline-adherent PORT at the patient, healthcare team, and organizational levels. NDURE is delivered via three in-person navigation sessions anchored to case identification and surgical care transitions. Intervention components include the following: (1) patient education, (2) travel support, (3) a standardized process for initiating the discussion of expectations for PORT, (4) PORT care plans, (5) referral tracking and follow-up, and (6) organizational restructuring. NDURE was feasible, as judged by accrual (88% of eligible patients [100% Blacks] enrolled) and dropout (n 5 0). One hundred percent of patients reported moderate or strong agreement that NDURE helped solve challenges starting PORT; 86% were highly likely to recommend NDURE. The rate of timely, guideline-adherent PORT was 86% overall and 100% for Black patients. CONCLUSION NDURE is a navigation-based MLI that is feasible, is acceptable, and has the potential to improve the timely, equitable, guideline-adherent PORT.

Original languageEnglish
Pages (from-to)E1512-E1523
JournalJCO Oncology Practice
Volume17
Issue number10
DOIs
StatePublished - Oct 1 2021

Bibliographical note

Publisher Copyright:
© 2021 by American Society of Clinical Oncology.

Funding

Supported by K12CA157688 and K08CA237858 from the National Cancer Institute (NCI) and DDCF2015209 from the Doris Duke Charitable Foundation to Dr Graboyes and by grant P30CA138313 from the NCI to the Biostatistics Shared Resource of the Hollings Cancer Center.

FundersFunder number
Hollings Cancer Center’s Cancer Center
National Childhood Cancer Registry – National Cancer InstituteP30CA138313, K08CA237858, DDCF2015209, K12CA157688
Doris Duke Charitable Foundation

    ASJC Scopus subject areas

    • Oncology
    • Health Policy
    • Oncology(nursing)

    Fingerprint

    Dive into the research topics of 'Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer'. Together they form a unique fingerprint.

    Cite this